The Profit Potential in the Opioid Epidemic
A journal for pharmaceutical investors takes a look at the profit potential in treating opioid use disorders.
The Impact of GLP-1 Drugs on Sex Drive
Ozempic and other GLP-1 drugs reduce the appetite in more ways than one. We examine the impact of GLP-1 drugs on sex drive.
Testing GLP-1 Drugs for Substance Use Disorders
Limited human trials of GLP-1 drugs for substance use disorders indicate they might not work well for non-obese individuals.
Does Ozempic Cause Weight Loss By Making People Sick?
We examine anecdotal reports and scientific evidence concerning gastrointestinal discomfort as a result of taking GLP-1 drugs.
Why Isn’t Big Pharma Investing in GLP-1 Trials for Substance Use Disorders?
There’s a noticeable lack of pharmaceutical company trials of GLP-1 drugs as treatments for substance use disorders.
Does Ozempic Cause Weight Loss by Impacting the Brain or the Gut?
A study from The Netherlands examines the impacts of GLP-1 agonists on the central nervous system using fMRI.